Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s12015-020-10017-6 http://scihub22266oqcxt.onion/10.1007/s12015-020-10017-6 32740890!7395577!32740890     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Stem+Cell+Rev+Rep 2021 ; 17 (1): 144-152 Nephropedia Template TP {{tp|p=32740890|t=2021. Stem Cells Therapy as a Possible Therapeutic Option in Treating COVID-19 Patients |pdf=|usr=}}{{32740890}} gab.com Text Stem Cells Therapy as a Possible Therapeutic Option in Treating COVID-19 Patients JO: Stem Cell Rev Rep http://www.kidney.de/pget.php?&tw=1&pmid=32740890 #FOAvip An unfortunate emergence of a new virus SARS-CoV-2, causing a disease known as COVID-19, has spread all around the globe and has caused a pandemic. It primarily affects the respiratory tract and lungs in some cases causing severe organ damage and pneumonia due to overwhelming immune responses. Clinical reports show that the most commons symptoms are fever, dry cough, and shortness of breath, along with several other symptoms. It is thought that an immense cytokine dysregulation in COVID-19 patients is caused following the virus infection. Notably, if patients present with pre-existing specific comorbidities like diabetes or high blood pressure, rates of COVID-19 induced complications and deaths are escalated. Mesenchymal stem cell (MSC) therapy has been shown to alleviate pneumonia and acute respiratory syndrome (ARDS) symptoms, through their immunomodulatory activities in COVID-19 patients. Although more research studies and clinical trial results are needed to elucidate the exact mechanism by which MSCs provide relief to COVID-19 infected patients. Results from clinical trials are encouraging as patients treated with MSCs, regain lung functions and have restored levels of cytokines and trophic factors underscoring the fact that stem cell therapy can be, at least, a complementary therapy to alleviate sufferings in COVID-19 patients. This review discusses the possible therapeutic uses of MSCs for treating COVID-19. Graphical Abstract. Twit Text FOAVip Stem Cells Therapy as a Possible Therapeutic Option in Treating COVID-19 Patients ????Stem Cell Rev Rep http://www.kidney.de/pget.php?&tw=1&pmid=32740890 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32740890 #FOAvip English Wikipedia <ref>{{Cite pmid|32740890}}</ref> Stem Cells Therapy as a Possible Therapeutic Option in Treating COVID-19 Patients #MMPMID32740890 Esquivel D; Mishra R; Soni P; Seetharaman R; Mahmood A; Srivastava A Stem Cell Rev Rep 2021[Feb]; 17 (1): 144-152 PMID32740890show ga An unfortunate emergence of a new virus SARS-CoV-2, causing a disease known as COVID-19, has spread all around the globe and has caused a pandemic. It primarily affects the respiratory tract and lungs in some cases causing severe organ damage and pneumonia due to overwhelming immune responses. Clinical reports show that the most commons symptoms are fever, dry cough, and shortness of breath, along with several other symptoms. It is thought that an immense cytokine dysregulation in COVID-19 patients is caused following the virus infection. Notably, if patients present with pre-existing specific comorbidities like diabetes or high blood pressure, rates of COVID-19 induced complications and deaths are escalated. Mesenchymal stem cell (MSC) therapy has been shown to alleviate pneumonia and acute respiratory syndrome (ARDS) symptoms, through their immunomodulatory activities in COVID-19 patients. Although more research studies and clinical trial results are needed to elucidate the exact mechanism by which MSCs provide relief to COVID-19 infected patients. Results from clinical trials are encouraging as patients treated with MSCs, regain lung functions and have restored levels of cytokines and trophic factors underscoring the fact that stem cell therapy can be, at least, a complementary therapy to alleviate sufferings in COVID-19 patients. This review discusses the possible therapeutic uses of MSCs for treating COVID-19. Graphical Abstract. |*COVID-19 Drug Treatment[MESH] |*Cell- and Tissue-Based Therapy[MESH] |*Mesenchymal Stem Cell Transplantation[MESH] |COVID-19/epidemiology/*therapy/virology[MESH] |Humans[MESH] |Pandemics[MESH]Stem Cells Therapy as a Possible Therapeutic Option in Treating COVID-(epmc).pdf DeepDyve Pubget Overpricing